340 related articles for article (PubMed ID: 33631651)
1. Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
Thanou A; Jupe E; Purushothaman M; Niewold TB; Munroe ME
J Autoimmun; 2021 May; 119():102615. PubMed ID: 33631651
[TBL] [Abstract][Full Text] [Related]
2. Pathways of impending disease flare in African-American systemic lupus erythematosus patients.
Munroe ME; Vista ES; Merrill JT; Guthridge JM; Roberts VC; James JA
J Autoimmun; 2017 Mar; 78():70-78. PubMed ID: 28162788
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.
Munroe ME; Vista ES; Guthridge JM; Thompson LF; Merrill JT; James JA
Arthritis Rheumatol; 2014 Jul; 66(7):1888-99. PubMed ID: 24578190
[TBL] [Abstract][Full Text] [Related]
4. A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus.
Munroe ME; Blankenship D; DeFreese D; Purushothaman M; DeJager W; Macwana S; Guthridge JM; Kamp S; Redinger N; Aberle T; Chakravarty EF; Arriens C; Li Y; Zeng H; McCarthy-Fruin KA; Osei-Onomahm SA; Thanarajasingam U; James JA; Jupe E
Arthritis Rheumatol; 2023 May; 75(5):723-735. PubMed ID: 36245261
[TBL] [Abstract][Full Text] [Related]
5. Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus.
Howe HS; Leung BPL
Cells; 2019 Dec; 9(1):. PubMed ID: 31892200
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory markers in systemic lupus erythematosus.
Aringer M
J Autoimmun; 2020 Jun; 110():102374. PubMed ID: 31812331
[TBL] [Abstract][Full Text] [Related]
8. Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges.
Chen J; Liao S; Zhou H; Yang L; Guo F; Chen S; Li A; Pan Q; Yang C; Liu HF; Pan Q
Front Immunol; 2021; 12():816956. PubMed ID: 35116040
[TBL] [Abstract][Full Text] [Related]
9. Deposition of Immune Complexes in Gingival Tissues in the Presence of Periodontitis and Systemic Lupus Erythematosus.
Pires JR; Nogueira MRS; Nunes AJF; Degand DRF; Pessoa LC; Damante CA; Zangrando MSR; Greghi SLA; de Rezende MLR; Sant'Ana ACP
Front Immunol; 2021; 12():591236. PubMed ID: 33841392
[TBL] [Abstract][Full Text] [Related]
10. Performance of cytokine models in predicting SLE activity.
Ruchakorn N; Ngamjanyaporn P; Suangtamai T; Kafaksom T; Polpanumas C; Petpisit V; Pisitkun T; Pisitkun P
Arthritis Res Ther; 2019 Dec; 21(1):287. PubMed ID: 31842967
[TBL] [Abstract][Full Text] [Related]
11. Predicting lupus flares: epidemiological and disease related risk factors.
Andrade SO; Julio PR; Nunes de Paula Ferreira D; Appenzeller S
Expert Rev Clin Immunol; 2021 Feb; 17(2):143-153. PubMed ID: 33393397
[No Abstract] [Full Text] [Related]
12. Systemic lupus erythematosus and infections.
Singh BK; Singh S
Reumatismo; 2020 Nov; 72(3):154-169. PubMed ID: 33213128
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus.
Catalina MD; Owen KA; Labonte AC; Grammer AC; Lipsky PE
J Autoimmun; 2020 Jun; 110():102359. PubMed ID: 31806421
[TBL] [Abstract][Full Text] [Related]
14. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus.
Tan G; Baby B; Zhou Y; Wu T
Front Immunol; 2021; 12():808839. PubMed ID: 35095896
[TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
16. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.
Bauer JW; Petri M; Batliwalla FM; Koeuth T; Wilson J; Slattery C; Panoskaltsis-Mortari A; Gregersen PK; Behrens TW; Baechler EC
Arthritis Rheum; 2009 Oct; 60(10):3098-107. PubMed ID: 19790071
[TBL] [Abstract][Full Text] [Related]
17. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Barnabei L; Ben Salah E; Cohen-Aubart F; Garrido Castillo L; Haroche J; Hie M; Pineton de Chambrun M; Miyara M; Sterlin D; Pha M; Lê Thi Huong D; Rieux-Laucat F; Rozenberg F; Gorochov G; Amoura Z
Arthritis Rheumatol; 2019 May; 71(5):756-765. PubMed ID: 30507062
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus multiorgan flare with quiescent serologic markers.
Gile JJ; Sara JDS; Mueller MR
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653839
[TBL] [Abstract][Full Text] [Related]
19. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS.
Koo M; Lu MC
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138199
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for systemic lupus erythematosus.
Ahearn JM; Liu CC; Kao AH; Manzi S
Transl Res; 2012 Apr; 159(4):326-42. PubMed ID: 22424435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
